Videos

Sponsored
In this video, Dr Danilov discusses the use of acalabrutinib as a treatment option for patients with CLL, SLL, and MCL.
Sponsored
In this video, Dr Graff talks about how the treatment landscape for CLL has evolved in recent years, especially with the introduction of acalabrutinib.
Sponsored
In this video, Dr Goy discusses recent innovations in the treatment of patients with MCL.
Adam M. Brufsky, MD, PhD, University of Pittsburgh School of Medicine, Magee-Women’s Cancer Program, Comprehensive Breast Cancer Center, UPMC Hillman Cancer Center, discusses "Evolving Strategies in…
Anthony Lucci, MD, University of Texas, MD Anderson Cancer Center, highlights the significant results following the recent study which evaluated the role of modified radical mastectomy (MRM) in…
Sponsored
Michael Morse, MD, FACP, MHS, discusses the role that microsatellite stability (MSS) or microsatellite instability (MSI) plays in metastatic CRC.
Sponsored
Ryan Corcoran, MD, PhD, discusses the characterization of BRAF mutations and the evolving treatment landscape for patients with BRAF/RAS mutations.
At the annual Miami Breast Cancer Conference, Kelly Hunt, MD, discussed the use of neoadjuvant endocrine therapy for patients with breast cancer.
Stay in the know.
OncNet Newsletter